Global Healthcare Convergence: Booming Market Driven by Technological Integration and Remote Patient Monitoring (2024-2031)
The healthcare convergence market, blending medical devices, digital health, telehealth, and remote patient monitoring, aims to [...]
Kyverna Therapeutics Eyes IPO Amid Rising Interest in CAR-T Therapy for Autoimmune Diseases
According to Endpoints News, Kyverna Therapeutics, a clinical-stage biotech specializing in CAR-T cell therapy for autoimmune [...]
Takeda Acquires Nimbus’ TYK2 Inhibitor TAK-279 in a $4 Billion Deal, Intensifying Competition in Immunology
In late 2022, Takeda moved significantly in the immunology sector by acquiring Nimbus Therapeutics’ tyrosine kinase [...]
Federal Judge Blocks IQVIA’s Acquisition of Propel Media, Citing Antitrust Concerns
A U.S. federal judge has issued a preliminary injunction at the Federal Trade Commission's (FTC) request, [...]
Infectious Diseases in 2024: Polio Eradication, Pandemic Preparedness, and Climate Change Impacts
As we approach the fifth year of this decade, there is a cautious return to normalcy [...]
German Court Invalidates CureVac’s mRNA Vaccine Patent in Dispute with BioNTech, Impacting Stocks and Ongoing Litigations
Here's what you need to know: A German court ruled against CureVac in a patent dispute [...]
Kaiser Permanente Awards Grants for AI and ML Research in Healthcare
The Kaiser Permanente Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center, part of the [...]
FDA Approves Merck’s Welireg for Expanded Use in Kidney Cancer, Boosting Sales Prospects
Merck’s cancer drug Welireg (belzutifan), approved in August 2021, has been making steady sales progress. Recently, [...]
AstraZeneca Buys Icosavax for $838 Million to Boost Vaccine R&D and Compete in RSV Market
AstraZeneca is acquiring Icosavax for $838 million upfront, aiming to strengthen its vaccine research and development. [...]
AbbVie Expands Neuroscience Portfolio with $8.7 Billion Acquisition of Cerevel Therapeutics
AbbVie has announced plans to acquire Cerevel Therapeutics, a neuroscience drugmaker, for $8.7 billion, marking its [...]
Consolidation of US Hospitals Leads to Increased Profits but Not Improved Care Quality, Study Finds
The consolidation of US hospitals increased between 2000 and 2020, with multi-unit hospital systems now owning [...]
AbbVie Expands Oncology Footprint with $10.1 Billion Acquisition of ImmunoGen
AbbVie, a pharmaceutical giant, announced its plan to acquire ImmunoGen, a clinical-stage biotech company specializing in [...]
Montrose Regional Health Joins Guardian Research Network’s Nationwide Healthcare Research Consortium
Guardian Research Network (GRN) has announced that Montrose Regional Health (MRH), a critical healthcare facility in [...]
EMD Serono to Relocate Headquarters to Boston’s Seaport District, Embracing Hybrid Work and Collaboration
EMD Serono, the US pharma subsidiary of Merck KGaA, is set to move its headquarters to [...]
Carl Icahn Files Lawsuit Against Illumina Board Over Controversial Grail Acquisition, Seeks Repayment and Board Removal
Billionaire Carl Icahn has launched a class-action lawsuit against the board of Illumina, claiming that they [...]
Teva and Cephalon Lose Appeal Against $60 Million Fine in Pay-for-Delay Scheme
Teva and its subsidiary Cephalon have lost their appeal against more than $60 million in fines [...]
Optimizing Clinical Trials for Greater Payer Acceptance and Enhanced Patient Access
Biopharma manufacturers face challenges in conveying the clinical value of their medicines to payers due to [...]
Recent Biopharmaceutical Updates: Workplace Cuts at Sana, NASH Treatment Setbacks, ALS Treatment Appeals, and Alnylam’s Future
Recent updates from the biopharmaceutical world: Sana Biotechnology: The company is laying off approximately one-third of [...]
FDA Denies Alnylam Pharmaceuticals’ Expansion Plans for Onpattro Treatment
The FDA has denied Alnylam Pharmaceuticals' request to expand the use of its siRNA injection Onpattro for the treatment of [...]
AbbVie Acquires Mitokinin for $110M Upfront to Enhance its Neuroscience Pipeline
Pharmaceutical company AbbVie has purchased biotech Mitokinin for $110 million upfront, potentially adding $545 million in milestone payments. The deal [...]
2023 Nobel Prize in Medicine Awarded to mRNA Researchers Katalin Karikó and Drew Weissman
Katalin Karikó and Drew Weissman, two pioneers of mRNA research, were awarded the 2023 Nobel Prize in Medicine or Physiology [...]
Integration of Digital Targeting in Addressable TV: Implications for Healthcare Marketers
Addressable TV—which uses digital targeting and measurements for television advertisements—is changing the marketing landscape. It allows healthcare marketers to reach [...]
Philip Morris Introduces LEVIA: A Tobacco-Free Alternative for IQOS Device
Philip Morris International (PMI) has announced a new product for its IQOS 'heat-not-burn' device: a tobacco-free stick named LEVIA. The [...]
Roche Acquires Two RNA-Targeted Drug Programs for Alzheimer’s and Huntington’s from Ionis Pharmaceuticals
Roche has obtained two RNA-targeted drug programs for Alzheimer's and Huntington's diseases from Ionis Pharmaceuticals. The deal involves a $60 [...]
Christine Davis Appointed as New President of Ontada
Ontada, a McKesson business focusing on oncology real-world data and evidence, has appointed Christine Davis as [...]